News

AddToAny

Google+ Facebook Twitter Twitter

New “fast, accurate” COVID sensor developed

A COVID-19 sensor developed at Johns Hopkins University could revolutionise virus testing.

A new study describes the sensor, which requires no sample preparation and minimal operator expertise.

The researchers say it offers an advantage over existing testing methods, especially for population-wide testing.

Ishan Barman, an Associate Professor of Mechanical Engineering, said: “The technique is as simple as putting a drop of saliva on our device and getting a negative or a positive result... this is a label-free technique, which means no additional chemical modifications are required.”

Barman says the new technology, which is not yet available on the market, addresses the limitations of PCR and rapid tests.

The sensor is nearly as sensitive as a PCR test and as convenient as a rapid antigen test.

During initial testing, the sensor demonstrated 92% accuracy at detecting SARS-COV-2 in saliva samples. The sensor was also highly successful at rapidly determining the presence of other viruses, including H1N1 and Zika.

bit.ly/3tNQx42

Image credit |Flexible FEMIA

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top